Global Influenza Market is projected to reach $9.33 billion by 2021

RESEARCH REPORT
JUN 2017
Influenza Market (2016-2021)
SEGMENTED BY SENSOR TYPE, BY TECHNIQUE, BY APPLICATION, BY LIGHT
EQUIPMENT, BY REGION AND END USERS, INDUSTRY ANALYSIS, SIZE, SHARE,
GROWTH TRENDS AND FORECASTS REPORTS
2016-2021

According to the report “The Global Influenza Market ", published by Market Data Forecast,
the global market is projected to reach USD 9.33 billion by 2021, at a CAGR of 8.54% from
2016 to 2021.
Influenza is a viral infection or infectious disease caused by the virus names “Influenza”,
that attacks your respiratory system like your lungs, nose and throat. Flu is the commonly
used name for Influenza. Influenza resolves on its own for most of the people. But
sometimes, influenza and its complications can be deadly higher risk of developing flu
complications for the people include Young children under 5, and those especially under 2
years,Adults above 65,Pregnant women.
Request Sample: http://www.marketdataforecast.com/market-reports/global-influenzamarket-1704/request-sample
Influenza viruses are mainly of three types-Type A (H1N1, H2N2, and H5N1, etc.), Type B,
and Type C. It can be either pandemic, seasonal, or zoonotic. Influenza can be fatal if goes
unnoticed and is regarded as a major reason of morbidity and mortality, globally. Some of
the symptoms of influenza are fever, cough, sore throat, runny or stuffy nose, fatigue,
headache, and body ache. The flu occurs infecting 5% to 10% adults and 20% to 30%
children, worldwide on annual basis according to WHO. Nearly, 3 to 5 million people gets
severely infected resulting in 250,000 – 500,000 deaths in a year. Children below 2 years of
age and elderly above 65 years of age are at high risk of developing chronic flu.
The factors influencing the Global Market for Influenza Market, either positively or
negatively are presented in the DROC analysis. Some of the things discussed in the section
are boost in Research & Development investment, rising public awareness, increase in
healthcare expenditure, cost-effectiveness of immunization, introduction of new medicines,
and increasing government initiatives for vaccination against influenza virus.
For granular level understanding The Global Influenza Market is segmented based on the
following categories with Market Size Estimations and Y-o-Y Forecasts presented for each
sub-segment.
1) By product Type:
Introduction
Vaccines
Drugs
Y-o-Y Growth Analysis, By Product
Market Attractiveness Analysis, By Product
Market Share Analysis, By Product
2) By Type:
Introduction

Safety Biomarkers
Efficacy Biomarkers
Validation Biomarkers
Y-o-Y Growth Analysis, By Type
Market Attractiveness Analysis, By Type
Market Share Analysis, By Type
3) By Application:
Introduction
Diagnostics Development
Drug Discovery and Development
Personalised Medicine
Disease Risk Assessment
Other Applications
Y-o-Y Growth Analysis, By Application
Market Attractiveness Analysis, By Application
Market Share Analysis, By Application
4) By Disease Indications:
Introduction
Cancer
Cardiovascular Disorders
Neurological Disorders
Immunological Disorders
Other Diseases
Y-o-Y Growth Analysis, By Disease Indications
Market Attractiveness Analysis, By Disease Indications
Market Share Analysis, By Disease Indications
Based on geography, the report contains a wide array of countries covering all around the
globe. Countries like Latin America, Canada, North America, U.K., Argentina, Spain, Iran,
Germany, Italy, India, China, South Africa, Israel and Brazil are identified as the predominant
markets for Optogenetics.
For more of regional analysis check out the following reports:

North America Influenza Market
Europe Influenza Market
Asia-Pacific Influenza Market
Latin America Influenza Market
Middle-East & Africa Influenza Market
The major companies dominating the global Influenza Market are Sanofi-Pasteur (U.S.), AstraZeneca
(United Kingdom), F. Hoffmann-La Roche (Switzerland), Novartis (Switzerland), GlaxoSmithKline
(U.K.), Pfizer Inc. (U.S.), Merck & Co. (U.S.), Abbott Laboratories (U.S.), Mitsubishi Tanabe Pharma
Corporation (Japan), CSL Limited (Australia).
The Influenza Market study offers the following deliverables:
Global, regional and country-level analysis and forecasts of the study market;
providing Insights on the geographical areas in which this industry is blooming
Segment-level analysis on basis of poduct type, application, colour along with
market size forecasts and y-o-y estimations to detect key areas of industry growth in
detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the
market and their impact on shifting market dynamics
Study of macro and micro environmental factors that effect the global market
presented in an extensive strategic analyses section containing PESTLE and Porter’s
Five Forces Analyses
A comprehensive listing of key market players along with company overview,
product portfolios, key financial information (subjected to availability), SWOT
analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations
in the field along with new product launches, comparative financial studies and
recent developments in the market by the major companies

TABLE OF CONTENTS
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
3. Overview
2.1 Introduction
2.2 Research Phases
2.3 Analysis Design
2.4 Study Timeline
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
Customized report URL: http://www.marketdataforecast.com/market-reports/globalinfluenza-market-1704/customize-report
4. Drivers, Restraints, Opportunities, and Challenges Analysis
(DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
Inquire Before Buying: http://www.marketdataforecast.com/market-reports/global-influenzamarket-1704/inquire
5. Market Segmentation
5.1 Product Type
5.1.1 Introduction
5.1.2 Vaccines

5.1.3 Drugs
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Type
5.2.1 Introduction
5.2.2 Safety Biomarkers
5.2.3 Efficacy Biomarkers
5.2.4 Validation Biomarkers
5.2.5 Y-o-Y Growth Analysis, By Type
5.2.6 Market Attractiveness Analysis, By Type
5.2.7 Market Share Analysis, By Type
5.3 Application
5.3.1 Introduction
5.3.2 Diagnostics Development
5.3.3 Drug Discovery and Development
5.3.4 Personalised Medicine
5.3.5 Disease Risk Assessment
5.3.6 Other Applications
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
5.4 Disease Indications
5.4.1 Introduction
5.4.2 Cancer
5.4.3 CardiovascularDisorders
5.4.4 Neurological Disorders
5.4.5 Immunological Disorders
5.4.6 Other Diseases
5.4.7 Y-o-Y Growth Analysis, By Disease Indications
5.4.8 Market Attractiveness Analysis, By Disease Indications
5.4.9 Market Share Analysis, By Disease Indications

For Full Report refer to: http://www.marketdataforecast.com/market-reports/globalinfluenza-market-1704/
6. Geographical Analysis
6.1 Introduction
6.2 North America
6.3 Europe
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type
6.1.3.4 By Application
6.1.3.5 By Indication
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Type
6.1.4.4 By Application
6.1.4.5 By Indication
6.1.5 Market Share Analysis
6.1.1 Introduction
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Type
6.1.2 United States
6.1.3 Canada
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.1.5.4 By Application
6.1.5.5 By Indication

6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry

8.Market Leaders' Analysis
8.1 Sanofi-Pasteur
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 AstraZeneca
8.3 F. Hoffmann-La Roche
8.4 Novartis
8.5 GlaxoSmithKline
8.6 Pfizer Inc.
8.7 Merck & Co.
8.8 Abbott Laboratories
8.9 Mitsubishi Tanabe Pharma Corporation
8.10 CSL Limited
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures

SCOPE OF THE REPORT
Regional and country-level analysis and forecasts of the study market; providing
Insights on the major countries/regions in which this industry is blooming and to also
identify the regions that are still untapped
Segment-level analysis in terms of technology, component, and type along with
market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the
market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global
market; which includes broadly demographic, economics, and political, among other
macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an
Industry, using Porter’s five forces analysis for analyzing the level of competition
and business strategy development
A comprehensive list of key market players along with their product portfolio,
current strategic interests, key financial information, legal issues, SWOT analysis and
analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations
in the field along with new product launches, comparative financial studies and
recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decisionmaking
personnel can rapidly become acquainted with background information,
concise analysis and main conclusions

ABOUT US
Market Data Forecast is a firm working in the areas of market research and business
intelligence. We have rich experience in research across various business domains and we
cater to the needs of both individual and corporate clients. Our research services assist
clients in key business areas like business process improvement, key decision making and
developing appropriate corporate strategy. We are truly committed to our clients and other
stakeholders for providing customized research services of the highest quality.
CONTACT INFORMATION
We always look forward to working with new clients, pushing our boundaries and extending
our reach beyond global horizons. Get in touch with us for further queries.
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
FOR MORE INFORMATION